Abstract
Previously, we found a significantly greater number of surviving CA1 neurons to global ischemia in the aged (24-month-old) F344 rats than in young (4-month-old) rats. The present study tests the hypothesis that aging retards neuronal death in the hippocampal CA1 region following cerebral ischemia. The CA1 living cell ratio was significantly greater in aged than in young rats at three days (62± 8% vs. 30± 8%) and at eight days (36± 6% vs. 17± 5%), but not at 14 days (15± 12% vs. 18± 12%) following ischemia. The number of the CA1 cells exhibiting co-localized TdT-mediated XdUTP nick end labeling reaction and caspase-3 active peptide (C3AP) immunoreactivity was greater in aged than young animals at three and eight days following ischemia (36± 8/mm vs. 3± 1/mm and 36± 14 vs. 0± 0, p < 0.05 respectively). Also, the total number of C3AP-positive cells in the CA1 region in the aged group was significantly greater than in the young group at three and eight days post-ischemia (p < 0.05). Aging appears to delay caspase-3-dependent apoptotic cell death induced by global ischemia in the CA1 region of the hippocampus, consistent with an age-induced neuroprotective process.
Keywords: Aging, experimental cerebral ischemia, caspase 3-TUNEL dual-labeling, neuroprotection, TUNEL
Current Neurovascular Research
Title: Aging is Neuroprotective During Global Ischemia but Leads to Increased Caspase-3 and Apoptotic Activity in Hippocampal Neurons
Volume: 3 Issue: 3
Author(s): Zhen He, James F. Meschia, Thomas G. Brott, Dennis W. Dickson and Michael Mckinney
Affiliation:
Keywords: Aging, experimental cerebral ischemia, caspase 3-TUNEL dual-labeling, neuroprotection, TUNEL
Abstract: Previously, we found a significantly greater number of surviving CA1 neurons to global ischemia in the aged (24-month-old) F344 rats than in young (4-month-old) rats. The present study tests the hypothesis that aging retards neuronal death in the hippocampal CA1 region following cerebral ischemia. The CA1 living cell ratio was significantly greater in aged than in young rats at three days (62± 8% vs. 30± 8%) and at eight days (36± 6% vs. 17± 5%), but not at 14 days (15± 12% vs. 18± 12%) following ischemia. The number of the CA1 cells exhibiting co-localized TdT-mediated XdUTP nick end labeling reaction and caspase-3 active peptide (C3AP) immunoreactivity was greater in aged than young animals at three and eight days following ischemia (36± 8/mm vs. 3± 1/mm and 36± 14 vs. 0± 0, p < 0.05 respectively). Also, the total number of C3AP-positive cells in the CA1 region in the aged group was significantly greater than in the young group at three and eight days post-ischemia (p < 0.05). Aging appears to delay caspase-3-dependent apoptotic cell death induced by global ischemia in the CA1 region of the hippocampus, consistent with an age-induced neuroprotective process.
Export Options
About this article
Cite this article as:
He Zhen, Meschia F. James, Brott G. Thomas, Dickson W. Dennis and Mckinney Michael, Aging is Neuroprotective During Global Ischemia but Leads to Increased Caspase-3 and Apoptotic Activity in Hippocampal Neurons, Current Neurovascular Research 2006; 3 (3) . https://dx.doi.org/10.2174/156720206778018802
DOI https://dx.doi.org/10.2174/156720206778018802 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Is the Cytoskeleton an Intracellular Receptor for Adrenomedullin and PAMP?
Current Protein & Peptide Science Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Inhibition of EGFR Signaling by N-cyclohexyl-2-(1-(phenylsulfonyl)piperidin-4-yl) acetamide
Anti-Cancer Agents in Medicinal Chemistry Flavonoids as Sirtuin Modulators
Current Topics in Medicinal Chemistry Immunomodulatory Properties of Antibiotics
Current Molecular Pharmacology Commentary (Research Highlights: Linking Productive Autophagy to Neuroprotection: Potential Implications for Anti-Ischemic Therapy)
CNS & Neurological Disorders - Drug Targets A Stress Repair Mechanism That Maintains Vertebrate Structure During Stress
Cardiovascular & Hematological Disorders-Drug Targets Targeting mTOR Pathways in Human Malignancies
Current Pharmaceutical Design The Updated Role of the Blood Brain Barrier in Subarachnoid Hemorrhage: From Basic and Clinical Studies
Current Neuropharmacology Cancer-Associated Carbonic Anhydrases and Their Inhibition
Current Pharmaceutical Design Clinical and Prognostic Implications of Cognitive Dysfunction and Depression in COPD
Current Respiratory Medicine Reviews TNF α Signaling Beholds Thalidomide Saga: A Review of Mechanistic Role of TNF-α Signaling Under Thalidomide
Current Topics in Medicinal Chemistry Genetic and Epigenetic Studies for Determining Molecular Targets of Natural Product Anticancer Agents
Current Cancer Drug Targets Lysophosphatidic Acid and Renal Fibrosis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Glucose Metabolism and Insulin Resistance in Sepsis
Current Pharmaceutical Design Mitochondria-Mediated Oxidative Stress: Old Target for New Drugs
Current Medicinal Chemistry Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease
CNS & Neurological Disorders - Drug Targets An Overview of Emerging Immunotargets of Genitourinary Tumors
Current Drug Targets Anti-metastatic Treatment in Colorectal Cancer: Targeting Signaling Pathways
Current Pharmaceutical Design Overview of Pediatric Epilepsy
Current Pediatric Reviews